Compare Stocks: QSI, CYRX, DNA, and PACB

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CYRX CryoPort	$18.14 +4.1%	$16.11	$7.61 ▼ $18.24	$882.81M	1.96	635,806 shs	1.05 million shs
DNA Ginkgo Bioworks	$15.06 +22.0%	$8.22	$5.37 ▼ $17.58	$831.65M	1.79	2.02 million shs	7.65 million shs
PACB Pacific Biosciences of California	$2.87 +13.0%	$1.45	$1.07 ▼ $2.92	$789.51M	2.19	13.30 million shs	26.18 million shs
QSI Quantum-Si	$1.28 -17.4%	$0.82	$0.69 ▼ $3.10	$339.27M	3.21	5.64 million shs	19.11 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CYRX CryoPort	+4.07%	+4.37%	+14.74%	+20.45%	+87.40%
DNA Ginkgo Bioworks	+22.08%	+43.16%	+116.73%	+60.67%	-6.67%
PACB Pacific Biosciences of California	+12.99%	+67.84%	+112.59%	+83.97%	+92.62%
QSI Quantum-Si	-17.42%	+61.01%	+67.10%	+39.21%	-25.58%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CYRX CryoPort	$18.14 +4.1%	$16.11	$7.61 ▼ $18.24	$882.81M	1.96	635,806 shs	1.05 million shs
DNA Ginkgo Bioworks	$15.06 +22.0%	$8.22	$5.37 ▼ $17.58	$831.65M	1.79	2.02 million shs	7.65 million shs
PACB Pacific Biosciences of California	$2.87 +13.0%	$1.45	$1.07 ▼ $2.92	$789.51M	2.19	13.30 million shs	26.18 million shs
QSI Quantum-Si	$1.28 -17.4%	$0.82	$0.69 ▼ $3.10	$339.27M	3.21	5.64 million shs	19.11 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CYRX CryoPort	+4.07%	+4.37%	+14.74%	+20.45%	+87.40%
DNA Ginkgo Bioworks	+22.08%	+43.16%	+116.73%	+60.67%	-6.67%
PACB Pacific Biosciences of California	+12.99%	+67.84%	+112.59%	+83.97%	+92.62%
QSI Quantum-Si	-17.42%	+61.01%	+67.10%	+39.21%	-25.58%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CYRX CryoPort	2.67	Moderate Buy	$18.38	1.30% Upside
DNA Ginkgo Bioworks	1.50	Reduce	$6.33	-57.95% Downside
PACB Pacific Biosciences of California	1.83	Reduce	$1.71	-40.33% Downside
QSI Quantum-Si	2.25	Hold	$2.50	95.31% Upside

Current Analyst Ratings Breakdown

Latest QSI, CYRX, DNA, and PACB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/1/2026	CYRX CryoPort	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$16.00 ➝ $19.00
9/29/2026	QSI Quantum-Si	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$4.00
9/28/2026	PACB Pacific Biosciences of California	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
9/24/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/18/2026	CYRX CryoPort	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$25.00
9/10/2026	PACB Pacific Biosciences of California	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/9/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
9/9/2026	DNA Ginkgo Bioworks	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$5.00
9/9/2026	PACB Pacific Biosciences of California	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$1.50 ➝ $1.35
9/4/2026	DNA Ginkgo Bioworks	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell	$5.00
8/25/2026	PACB Pacific Biosciences of California	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 10/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CYRX CryoPort	$176.18M	5.22	N/A	N/A	$9.19 per share	1.97
DNA Ginkgo Bioworks	$170.15M	5.96	N/A	N/A	$8.74 per share	1.72
PACB Pacific Biosciences of California	$160.01M	5.58	$0.89 per share	3.22	$0.02 per share	143.50
QSI Quantum-Si	$2.44M	114.82	N/A	N/A	$1.02 per share	1.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CYRX CryoPort	$78.30M	-$0.90	N/A	N/A	N/A	-20.05%	-7.20%	-4.30%	11/3/2026 (Estimated)
DNA Ginkgo Bioworks	-$312.76M	-$5.01	N/A	N/A	N/A	-259.96%	-60.27%	-26.88%	11/5/2026 (Estimated)
PACB Pacific Biosciences of California	-$546.38M	-$0.43	N/A	N/A	N/A	-82.49%	-5,752.12%	-19.52%	11/3/2026 (Estimated)
QSI Quantum-Si	-$101.34M	-$0.46	N/A	N/A	N/A	-6,138.26%	-47.12%	-43.18%	11/4/2026 (Estimated)

Latest QSI, CYRX, DNA, and PACB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/3/2026	Q3 2026	CYRX CryoPort	-$0.19	N/A	N/A	N/A	$48.69 million	N/A
11/3/2026	Q3 2026	PACB Pacific Biosciences of California	-$0.1260	N/A	N/A	N/A	$43.82 million	N/A
8/13/2026	Q2 2026	QSI Quantum-Si	-$0.1133	-$0.11	+$0.0033	-$0.11	$0.30 million	$0.34 million
8/6/2026	Q2 2026	CYRX CryoPort	-$0.1933	-$0.20	-$0.0067	-$0.20	$48.18 million	$48.97 million
8/5/2026	Q2 2026	DNA Ginkgo Bioworks	-$0.8950	-$0.75	+$0.1450	-$0.75	$24.05 million	$20.16 million
8/3/2026	Q2 2026	PACB Pacific Biosciences of California	-$0.1280	-$0.14	-$0.0120	-$0.14	$42.90 million	$39.01 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CYRX CryoPort	N/A	N/A	N/A	N/A	N/A
DNA Ginkgo Bioworks	N/A	N/A	N/A	N/A	N/A
PACB Pacific Biosciences of California	N/A	N/A	N/A	N/A	N/A
QSI Quantum-Si	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CYRX CryoPort	N/A	2.08	1.98
DNA Ginkgo Bioworks	N/A	4.57	4.57
PACB Pacific Biosciences of California	N/A	4.92	4.03
QSI Quantum-Si	N/A	9.97	9.80

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CYRX CryoPort	92.90%
DNA Ginkgo Bioworks	78.63%
PACB Pacific Biosciences of California	N/A
QSI Quantum-Si	39.90%

Insider Ownership

Company	Insider Ownership
CYRX CryoPort	9.50%
DNA Ginkgo Bioworks	12.69%
PACB Pacific Biosciences of California	3.70%
QSI Quantum-Si	22.04%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CYRX CryoPort	738	50.65 million	45.84 million	Optionable
DNA Ginkgo Bioworks	485	67.34 million	58.80 million	Optionable
PACB Pacific Biosciences of California	485	310.83 million	299.33 million	Optionable
QSI Quantum-Si	145	218.88 million	170.64 million	Optionable

QSI, CYRX, DNA, and PACB Headlines

Recent News About These Companies

Quantum-Si (NASDAQ:QSI) Rating Lowered to "Sell" at Wall Street Zen

October 3 at 1:19 AM | americanbankingnews.com

Quantum-Si (NASDAQ:QSI) Cut to "Sell" at Wall Street Zen

October 3 at 1:17 AM | marketbeat.com

3 Biotech Stocks Put Traders Are Targeting Today

October 1, 2026 | schaeffersresearch.com

HC Wainwright Reaffirms Buy Rating for Quantum-Si (NASDAQ:QSI)

October 1, 2026 | americanbankingnews.com

Stock Traders Purchase High Volume of Quantum-Si Call Options (NASDAQ:QSI)

September 30, 2026 | marketbeat.com

Quantum-Si (NASDAQ:QSI) Given "Buy" Rating at HC Wainwright

September 29, 2026 | marketbeat.com

H.C. Wainwright Reiterates Buy Rating on Quantum-SI Inc. (QSI)

September 29, 2026 | streetinsider.com

Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro

September 28, 2026 | financialpost.comF

Quantum-Si Reports Interim Proteus Platform Data Showing Significant Performance Gains Over Platinum Pro

September 28, 2026 | quiverquant.comQ

Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro

September 28, 2026 | globenewswire.com

Quantum-Si Incorporated $QSI Shares Sold by State Street Corp

September 27, 2026 | marketbeat.com

Quantum-Si (NASDAQ:QSI) CEO Jeffrey Alan Hawkins Sells 20,143 Shares

September 24, 2026 | insidertrades.com

Insider Selling: Quantum-Si (NASDAQ:QSI) CEO Sells $15,308.68 in Stock

September 23, 2026 | marketbeat.com

Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™

September 15, 2026 | globenewswire.com

Quantum-Si (NASDAQ:QSI) Upgraded by Wall Street Zen to Hold Rating

September 12, 2026 | marketbeat.com

Quantum-Si Flat on Kicking off Roadshow

September 10, 2026 | baystreet.ca

Quantum-Si (NASDAQ:QSI) Shares Down 1.3% - What's Next?

September 10, 2026 | marketbeat.com

Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities

September 9, 2026 | globenewswire.com

Quantum‑Si Earnings Call: Proteus Delay, Runway Extended

August 22, 2026 | theglobeandmail.com

Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

August 18, 2026 | globenewswire.com

Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

QSI, CYRX, DNA, and PACB Company Descriptions

CryoPort NASDAQ:CYRX

$18.14 +0.71 (+4.07%)

Closing price 10/5/2026 04:00 PM Eastern

Extended Trading

$18.16 +0.02 (+0.09%)

As of 07:06 AM Eastern

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Ginkgo Bioworks NYSE:DNA

$15.06 +2.71 (+21.97%)

Closing price 10/5/2026 03:59 PM Eastern

Extended Trading

$15.09 +0.03 (+0.18%)

As of 07:08 AM Eastern

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Pacific Biosciences of California NASDAQ:PACB

$2.87 +0.33 (+12.99%)

Closing price 10/5/2026 04:00 PM Eastern

Extended Trading

$2.94 +0.06 (+2.26%)

As of 07:11 AM Eastern

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Quantum-Si NASDAQ:QSI

$1.28 -0.27 (-17.42%)

Closing price 10/5/2026 04:00 PM Eastern

Extended Trading

$1.29 +0.01 (+0.78%)

As of 07:10 AM Eastern

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest QSI, CYRX, DNA, and PACB Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest QSI, CYRX, DNA, and PACB Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

QSI, CYRX, DNA, and PACB Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

QSI, CYRX, DNA, and PACB Company Descriptions

CryoPort NASDAQ:CYRX

Ginkgo Bioworks NYSE:DNA

Pacific Biosciences of California NASDAQ:PACB

Quantum-Si NASDAQ:QSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest QSI, CYRX, DNA, and PACB Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest QSI, CYRX, DNA, and PACB Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

QSI, CYRX, DNA, and PACB Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

QSI, CYRX, DNA, and PACB Company Descriptions

CryoPort NASDAQ:CYRX

Ginkgo Bioworks NYSE:DNA

Pacific Biosciences of California NASDAQ:PACB

Quantum-Si NASDAQ:QSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools